氧氟沙星+地塞米松治疗中耳炎临床疗效观察及安全性评价
Journal: Frontier Forum of Clinical Medicine DOI: 10.12238/ffcr.v3i5.16232
Abstract
目的：剖析中耳炎联用氧氟沙星和地塞米松的作用。方法：随机均分2024年1月-2025年6月本院接诊中耳炎病人（N=110）。试验组用氧氟沙星和地塞米松，对照组用氧氟沙星。对比听力阈值等指标。结果：关于鼓膜充血、耳痛与发热缓解时间：试验组短于对照组（P＜0.05）。听力阈值：治疗后，试验组（19.05±3.04）dB，对照组（20.97±3.76）dB，差异显著（P＜0.05）。总有效率：试验组96.36%，对照组80.0%，P＜0.05。不良反应：试验组3.64%，对照组7.27%，P＞0.05。结论：中耳炎病人联用氧氟沙星和地塞米松，其症状缓解与听力阈值均得到显著改善，疗效显著提升，用药安全性也较高。
Keywords
氧氟沙星；听力阈值；中耳炎；地塞米松
Full Text
PDF - Viewed/Downloaded: 0 TimesReferences
[1] 庞丽美. 观察注射用地塞米松磷酸钠与氧氟沙星滴耳液联合治疗急性化脓性中耳炎的临床效果[J]. 中国实用医药,2025,20(8):120-123.
[2] 欧阳晨枫,师国军,何磊. 地塞米松+左氧氟沙星治疗化脓性中耳炎患者的疗效及对炎症因子水平的影响探讨[J]. 中外医疗,2024,43(33):23-26.
[3] 杨贺鹏,杨长君,常慧. 地塞米松结合左氧氟沙星治疗化脓性中耳炎的效果及对患者听力水平、炎性指标的影响[J]. 临床医学工程,2024,31(11):1375-1376.
[4] JAMES DEMPSEY, JESSICA DANIELS, ROULLA KATIRI, et al. Prioritisation of head, neck, and respiratory outcomes in mucopolysaccharidosis type II: lessons from a rare disease consensus exercise and comparison of parental and clinical priorities[J]. Orphanet Journal of Rare Diseases,2025,20(1):152-155.
[5] 杨家庆,陈婷婷,叶其恩,等. 地塞米松磷酸钠注射液联合氧氟沙星滴耳液治疗急性化脓性中耳炎的疗效[J]. 临床合理用药,2024,17(27):148-151.
[6] ENDALU TESFAYE GUTETA, FEDASAN ALEMU ABDI, SEIFU GIZAW FEYISA, et al. Bacterial etiologies, antimicrobial susceptibility profiles and associated factors among patients with otitis media referred to Nekemte Public Health Research and Referral Laboratory Center, Western Ethiopia: A cross-sectional study[J]. BMC Microbiology,2025,25(1):129-132.
[7] 雷雯阳,余文婷,钟钰,等. 盐酸左氧氟沙星滴耳液与地塞米松注射液联合治疗中耳炎的临床研究进展[J]. 临床医学进展,2024,14(5):1842-1848.
[8] 马小华,向龙春,陈永让,等. 盐酸左氧氟沙星滴耳液联合地塞米松治疗急性化脓性中耳炎的效果[J]. 中外医学研究,2024,22(15):128-131.
[9] 钟锦群. 氧氟沙星滴耳液联合地塞米松磷酸钠注射液治疗中耳炎的临床研究[J]. 现代诊断与治疗,2023,34(22):3380-3382.
[2] 欧阳晨枫,师国军,何磊. 地塞米松+左氧氟沙星治疗化脓性中耳炎患者的疗效及对炎症因子水平的影响探讨[J]. 中外医疗,2024,43(33):23-26.
[3] 杨贺鹏,杨长君,常慧. 地塞米松结合左氧氟沙星治疗化脓性中耳炎的效果及对患者听力水平、炎性指标的影响[J]. 临床医学工程,2024,31(11):1375-1376.
[4] JAMES DEMPSEY, JESSICA DANIELS, ROULLA KATIRI, et al. Prioritisation of head, neck, and respiratory outcomes in mucopolysaccharidosis type II: lessons from a rare disease consensus exercise and comparison of parental and clinical priorities[J]. Orphanet Journal of Rare Diseases,2025,20(1):152-155.
[5] 杨家庆,陈婷婷,叶其恩,等. 地塞米松磷酸钠注射液联合氧氟沙星滴耳液治疗急性化脓性中耳炎的疗效[J]. 临床合理用药,2024,17(27):148-151.
[6] ENDALU TESFAYE GUTETA, FEDASAN ALEMU ABDI, SEIFU GIZAW FEYISA, et al. Bacterial etiologies, antimicrobial susceptibility profiles and associated factors among patients with otitis media referred to Nekemte Public Health Research and Referral Laboratory Center, Western Ethiopia: A cross-sectional study[J]. BMC Microbiology,2025,25(1):129-132.
[7] 雷雯阳,余文婷,钟钰,等. 盐酸左氧氟沙星滴耳液与地塞米松注射液联合治疗中耳炎的临床研究进展[J]. 临床医学进展,2024,14(5):1842-1848.
[8] 马小华,向龙春,陈永让,等. 盐酸左氧氟沙星滴耳液联合地塞米松治疗急性化脓性中耳炎的效果[J]. 中外医学研究,2024,22(15):128-131.
[9] 钟锦群. 氧氟沙星滴耳液联合地塞米松磷酸钠注射液治疗中耳炎的临床研究[J]. 现代诊断与治疗,2023,34(22):3380-3382.
Copyright © 2025 孙宇
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License